Clinical Trials in Colorado

Showing 9901-9920 of 13,761 trials

Peri-orbital and Peri-oral Wrinkle Reduction Trial

NCT01981252

This is prospective, multi-center, single-blinded, non-randomized clinical trial. Enrolled subjects will receive two Ulthera® treatments on the peri-orbital and peri-oral regions, each treatment provided 30 days apart. Follow-up visits will occur at 90 and 180 days following treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit.

Peri-orbital WrinklesPeri-oral Wrinkles

Ulthera, Inc90 participantsStarted Oct 2013

Beverly Hills, California, United States • Laguna Beach, California, United States • Englewood, Colorado, United States +2 more locations

COMPLETEDPhase 244 miles

Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease

NCT02197130

This study is a 26 week, randomized, parallel group, double blind comparison of PF-02545920 5 mg, PF-02545920 20 mg, and placebo dosed BID in the treatment of motor impairment of subjects with Huntington's Disease. A total of approximately 260 subjects are planned to be randomized in the study. Primary endpoint is the change from baseline in the Total Motor Score (TMS) assessment of the Unified Huntington Disease Rating Scale (UHDRS) after 26 weeks of treatment. secondary endpoints will include change from baseline in the Total Maximum Chorea (TMC) score of the UHDRS after 13 and 26 weeks of treatment and Clinical Global Impression-Improvement score after 13 and 26 weeks of treatment.

Huntington's Disease

Pfizer272 participantsStarted Sep 2014

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +54 more locations

Peri-orbital and Peri-oral Wrinkle Reduction Trial

Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease

Find Trials by Condition in Colorado

A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers

Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva

A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors

Safety Escalating Repeat IV, in Stroke Patients

Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer

A Multi-center Clinical Trial of the Misago™ Self-Expanding Stent System for Superficial Femoral Artery

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older

Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections

A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199

Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer

Clinical Evaluation of Patients With X-linked Retinoschisis

Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study

Proof of Concept (POC) in Patients With Ischaemic Stroke

A Study of the Ulthera® System for the Treatment of Axillary Hyperhidrosis

Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease

A Study of ABT-806 in Subjects With Advanced Solid Tumor Types